These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 12018966

  • 21. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G, Abou-Khalil B.
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG, Lischetzki G, Trollmann R, Rascher W, Rauh M.
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [Abstract] [Full Text] [Related]

  • 24. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE.
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Sodium valproate induced tremor in a patient with epilepsy and Down's syndrome.
    Siniscalchi A, Gallelli L, Loizzo S, Tiziana A, Russo E, De Sarro G.
    Curr Drug Saf; 2013 Feb; 8(1):69-71. PubMed ID: 23656451
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
    Machado RA, García VF, Astencio AG, Cuartas VB.
    Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M, Abramson RK.
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The prescribing of antiepileptic drugs for pregnant Australian women.
    Vajda FJ, Horgan D, Hollingworth S, Graham J, Hitchcock AA, Roten A, O'Brien TJ, Lander CM, Eadie MJ.
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ, O'Brien TJ, Graham JE, Lander CM, Eadie MJ.
    Neurology; 2013 Sep 10; 81(11):999-1003. PubMed ID: 23911758
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Valproate prescriptions for nonepilepsy disorders in reproductive-age women.
    Adedinsewo DA, Thurman DJ, Luo YH, Williamson RS, Odewole OA, Oakley GP.
    Birth Defects Res A Clin Mol Teratol; 2013 Jun 10; 97(6):403-8. PubMed ID: 23733498
    [Abstract] [Full Text] [Related]

  • 38. Valproate-induced hyperammonemic encephalopathy with normal liver function.
    Rath A, Naryanan TJ, Chowdhary GV, Murthy JM.
    Neurol India; 2005 Jun 10; 53(2):226-8. PubMed ID: 16010067
    [Abstract] [Full Text] [Related]

  • 39. The scope and use of valproate in epilepsy.
    Penry JK, Dean JC.
    J Clin Psychiatry; 1989 Mar 10; 50 Suppl():17-22. PubMed ID: 2494154
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.